Critically ill patients with acute hypoxic respiratory failure receive supplemental oxygen as a component of their treatment. In recent years, exposure to high levels of FiO2 with resultant “hyperoxia” have been associated with increased mortality in critically ill patients. At present, there is no clinical practice guideline on oxygenation targets for adult patients with hypoxic respiratory failure. In this podcast, we discuss the recently published HOT-ICU trial that evaluated a lower versus high oxygenation target in adult patients with acute hypoxic respiratory failure.
You can get CME credit for this episode here!Click here for CME Account Creation Instructions
Both NIV and HFNC are used to treat patients with acute respiratory failure. Current guidelines recommend NIV for acute respiratory failure caused by COPD...
More than 1.5 million patients are intubated each year in the United States. In up to 20% of patients, the first attempt at intubation...
Acute hypoxemic respiratory failure is a leading cause of ICU admission worldwide. Oxygen is first-line therapy for patients with acute hypoxemic respiratory failure and...
